Gritstone and CEPI expand agreement for SAM vaccine to target SARS-CoV-2 Omicron variant Dec. 7, 2021
EIDD-2749 shows broad antiviral activity against RSV, SARS-CoV-2 and related RNA viruses Dec. 7, 2021